The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N'-(3-isoquinolylmethyl)-N'-[[(3R)-1,2,3,4-tetrahydroisoquinolin-3-yl]methyl]butane-1,4-diamine ID: ALA4176370
PubChem CID: 135313757
Max Phase: Preclinical
Molecular Formula: C24H30N4
Molecular Weight: 374.53
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: NCCCCN(Cc1cc2ccccc2cn1)C[C@H]1Cc2ccccc2CN1
Standard InChI: InChI=1S/C24H30N4/c25-11-5-6-12-28(17-23-13-19-7-1-3-9-21(19)15-26-23)18-24-14-20-8-2-4-10-22(20)16-27-24/h1-4,7-10,13,15,24,27H,5-6,11-12,14,16-18,25H2/t24-/m1/s1
Standard InChI Key: KFPMIJKGKHDSQV-XMMPIXPASA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
34.2141 -12.5511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2128 -13.3785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9278 -13.7914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9260 -12.1382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6414 -12.5474 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6402 -13.3759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.3532 -13.7890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0719 -13.3780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0732 -12.5495 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.3555 -12.1319 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7854 -13.7925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.7830 -14.6176 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.4965 -15.0321 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0673 -15.0281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2121 -14.6215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9217 -15.0375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9212 -13.3874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2090 -13.7996 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.3540 -14.6136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6383 -15.0241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9249 -14.6096 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2092 -15.0201 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.6396 -13.8017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6343 -14.6245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3429 -15.0386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0575 -14.6312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.0588 -13.8053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3495 -13.3949 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
8 11 1 1
11 12 1 0
12 13 1 0
12 14 1 0
13 15 1 0
15 16 2 0
16 24 1 0
23 17 1 0
17 18 2 0
18 15 1 0
14 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 23 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 374.53Molecular Weight (Monoisotopic): 374.2470AlogP: 3.49#Rotatable Bonds: 8Polar Surface Area: 54.18Molecular Species: BASEHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 10.22CX LogP: 3.01CX LogD: -1.05Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.59Np Likeness Score: -0.15
References 1. Wilson RJ, Jecs E, Miller EJ, Nguyen HH, Tahirovic YA, Truax VM, Kim MB, Kuo KM, Wang T, Sum CS, Cvijic ME, Paiva AA, Schroeder GM, Wilson LJ, Liotta DC.. (2018) Synthesis and SAR of 1,2,3,4-Tetrahydroisoquinoline-Based CXCR4 Antagonists., 9 (1): [PMID:29348805 ] [10.1021/acsmedchemlett.7b00381 ]